Innovent Biologics Inc.’s efdamrofusp alfa (IBI-302) met the primary endpoint in phase II, showing a gain of 10 or more letters in visual acuity from baseline at one year in Chinese patients with ...

First quarter 2025 results presentations were the first chance analysts have had to quiz pharma companies in public about their exposure to the threat of U.S. import tariffs and what action they are ...

Scott Jennings has become so much a part of CNN in recent months, one can argue, that he has become almost as familiar as ...

Warner Bros. Discovery has re-upped its contract with Bioworld, the merchandise company it has partnered with for decades, ...